In this meta-analysis of nearly 50 000 participants from clinical outcome trials of sodium glucose cotransporter 2 ... major factor limiting the optimal use of RAAS inhibitors, which form the basis of ...

Phase 1 trial of TIM-3 inhibitor cobolimab monotherapy and in combination with PD-1 inhibitors nivolumab or dostarlimab (AMBER). This is an ASCO Meeting Abstract from the 2022 ASCO Annual Meeting I.

Selagine, Inc., a spin-out company from the University of Illinois Chicago (UIC), announced today that the U.S. Food and Drug Administration (FDA) has granted Investigational New Drug (IND) clearance ...

Clinical trials are at the forefront of medicine and allow for new ... basic ethical principles discussed by the National Commission for the Protection of Human Subjects of Biomedical and Behavioral ...

A Chinese startup has opened the world’s first clinic in Saudi Arabia where artificial intelligence diagnoses patients, a key step in replacing human doctors as the first line of medical treatment.

13 While individual-level surrogacy can be easily tested with individual patient data from any patient series, including nonrandomized series, treatment- or trial-level surrogacy requires a ...

With biomedical data collected by Sleuth Insights, researchers helped sculpt a version of OpenAI’s o3-mini model using scientific literature and findings from 430 clinical trials spanning ...

Part of the HHS transformation involves decreasing the NIH workforce by about 1,200 “by centralizing procurement, human ... in some form of medical research. “Clinical trials are a key part ...

His statement before the Senate HELP Committee seems to contradict news reports and former agency staff, who say deep funding cuts have halted scientific research and clinical trials across the ...

mimicking the bottom-up way norms form in human cultures. Even more strikingly, the team observed collective biases that couldn’t be traced back to individual agents. “Bias doesn’t always ...

“We are very encouraged by these first-in-human safety and pharmacokinetic data and how ... the data from preclinical and clinical trials may not support the safety, efficacy and tolerability of ...

Results from a first-in-human clinical trial in subjects with mucopolysaccharidosis type I (MPS I) Date and Location: Wednesday, May 14 th, 1:30 PM—3:15 PM CT, New Orleans Theater B.